Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zebrafish Avatars for CRLM Treatment Evaluation
NCT05289076Phase 2Unknown
- Start
- May 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in colorectal cancer with liver metastasis (CRLM). Primary endpoints: Successful tumour growth in zebra fish embryos at 3 days and Response evaluation of different combinations of chemotherapy in zebra fish embryos implanted with colorectal liver metastatic tissue at 3 days. Status: unknown.
02
Conditions
colorectal cancer with liver metastasis (CRLM)
Beyond the preview
Go deeper on NCT05289076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289076.